Flow cytometric analysis of neutrophil myeloperoxidase expression in

Gating strategy for quantifying peripheral blood neutrophil myeloperoxidase (MPO) expression. Tatiana Raskovalova et al.

Monoparametric histograms of peripheral blood neutrophil myeloperoxidase (MPO) expression. Tatiana Raskovalova et al. Haematologica

Baseline patients’ characteristics and neutrophil myeloperoxidase expression parameters measured by flow cytometric analysis in

Flow cytometric robust coefficient of variation estimates for neutrophil myeloperoxidase expression in peripheral blood

Area under the receiver operating characteristic curve for flow cytometric parameters of peripheral blood

Accuracy point estimates (95% confidence interval) for predefined thresholds of robust coefficient of variation

Baseline characteristics for 68 consecutive patients with suspected myelodysplastic syndromes enrolled in the prospective

Slides: 8

Download presentation

Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study by Tatiana Raskovalova, Marc G. Berger, Marie-Christine Jacob, Sophie Park, Lydia Campos, Carmen Mariana Aanei, Julie Kasprzak, Bruno Pereira, José Labarère, Jean-Yves Cesbron, and Richard Veyrat-Masson haematol Volume 104(12): 2382 -2390 December 1, 2019 © 2019 by Ferrata Storti Foundation

Baseline patients’ characteristics and neutrophil myeloperoxidase expression parameters measured by flow cytometric analysis in peripheral blood for myelodysplastic syndrome cases and controls. Tatiana Raskovalova et al. Haematologica 2019; 104: 23822390 © 2019 by Ferrata Storti Foundation

Flow cytometric robust coefficient of variation estimates for neutrophil myeloperoxidase expression in peripheral blood according to myelodysplastic syndrome type. Tatiana Raskovalova et al. Haematologica 2019; 104: 23822390 © 2019 by Ferrata Storti Foundation

Area under the receiver operating characteristic curve for flow cytometric parameters of peripheral blood neutrophil myeloperoxidase expression in discriminating myelodysplastic syndromes (MDS). Tatiana Raskovalova et al. Haematologica 2019; 104: 23822390 © 2019 by Ferrata Storti Foundation

Accuracy point estimates (95% confidence interval) for predefined thresholds of robust coefficient of variation for peripheral blood neutrophil myeloperoxidase expression in discriminating myelodysplastic syndromes. Tatiana Raskovalova et al. Haematologica 2019; 104: 23822390 © 2019 by Ferrata Storti Foundation

Baseline characteristics for 68 consecutive patients with suspected myelodysplastic syndromes enrolled in the prospective validation study. Tatiana Raskovalova et al. Haematologica 2019; 104: 23822390 © 2019 by Ferrata Storti Foundation